OTCPK:ARLZQ - Post by User
Comment by
kuatoliveson Oct 04, 2016 6:36am
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
75 Views
Post# 25305596
RE:RE:Big Acquisition!
RE:RE:Big Acquisition!These guys aren't fooling around. Adams must have a few contacts to be pulling off these kind of deals. Kinda scary the numbers being thrown around now, but if it makes me money, have at er.
"AstraZeneca recorded U.S. net revenues from Toprol-XL and its AG of $89 million and $53 million in 2015 and year-to-date June 2016, respectively."
Am I reading this right that Toprol-XL sold as much up till June 2016 as all of last year? That would be pretty big growth for AstraZenica to give up, or is the revenue just too small overall for them to bother with? Am I reading this right that we're looking at around +36million for Q4 (in addition to Yosprala and everything else?) Someone help me out here. Why am I and snootchy the only ones awake at this hour? Wake up people, jeez.